last data update: 2011/10/14, 06:20
Website loading time
during the test: 2.41 s
cable connection (average): 2.63 s
DSL connection (average): 2.84 s
modem (average): 14.31 s
HTTP headers
HTTP/1.1 301 Moved Permanently
Date: Fri, 14 Oct 2011 13:45:30 GMT
Server: Apache
Location: http://www.gekkowire.com/
Vary: Accept-Encoding
Content-Length: 233
Connection: close
Content-Type: text/html; charset=iso-8859-1
HTTP/1.1 200 OK
Date: Fri, 14 Oct 2011 13:45:31 GMT
Server: Apache
X-Pingback: http://www.gekkowire.com/xmlrpc.php
Pragma: Public
Cache-Control: no-cache, must-revalidate, no-transform
Vary: User-Agent,Accept,Accept-Encoding
Content-Length: 85281
Connection: close
Content-Type: text/html; charset=UTF-8
Information about DNS servers
gekkowire.com | SOA | ns1.dreamhost.com | hostmaster.dreamhost.com | 2011020902 | 16881 1800 1814400 14400 IN 14400 |
gekkowire.com | MX | 0 | mx1.sub3.homie.mail.dreamhost.com | IN | 14400 |
gekkowire.com | MX | 0 | mx2.sub3.homie.mail.dreamhost.com | IN | 14400 |
gekkowire.com | A | 69.163.150.255 | IN | 14400 | |
gekkowire.com | NS | ns1.dreamhost.com | IN | 14400 | |
gekkowire.com | NS | ns2.dreamhost.com | IN | 14400 | |
gekkowire.com | NS | ns3.dreamhost.com | IN | 14400 |
Received from the first DNS server
Request to the server "gekkowire.com"
You used the following DNS server:
DNS Name: ns1.dreamhost.com
DNS Server Address: 66.33.206.206#53
DNS server aliases:
HEADER opcode: REQUEST, status: NOERROR, id: 17912
flag: qr aa rd REQUEST: 1, ANSWER: 7, AUTHORITY: 0, ADDITIONAL: 5
REQUEST SECTION:
gekkowire.com. IN ANY
ANSWER SECTION:
gekkowire.com. 14400 IN MX 0 mx1.sub3.homie.mail.dreamhost.com.
gekkowire.com. 14400 IN SOA ns1.dreamhost.com. hostmaster.dreamhost.com. 2011020902 16881 1800 1814400 14400
gekkowire.com. 14400 IN NS ns1.dreamhost.com.
gekkowire.com. 14400 IN NS ns2.dreamhost.com.
gekkowire.com. 14400 IN MX 0 mx2.sub3.homie.mail.dreamhost.com.
gekkowire.com. 14400 IN A 69.163.150.255
gekkowire.com. 14400 IN NS ns3.dreamhost.com.
SECTION NOTES:
ns3.dreamhost.com. 14400 IN A 66.33.216.216
mx1.sub3.homie.mail.dreamhost.com. 14400 IN A 208.97.132.221
ns1.dreamhost.com. 14400 IN A 66.33.206.206
ns2.dreamhost.com. 14400 IN A 208.96.10.221
mx2.sub3.homie.mail.dreamhost.com. 14400 IN A 208.97.132.222
Received 294 bytes from address 66.33.206.206#53 in 76 ms
Received from the second DNS server
Request to the server "gekkowire.com"
You used the following DNS server:
DNS Name: ns2.dreamhost.com
DNS Server Address: 208.96.10.221#53
DNS server aliases:
HEADER opcode: REQUEST, status: NOERROR, id: 14103
flag: qr aa rd REQUEST: 1, ANSWER: 7, AUTHORITY: 0, ADDITIONAL: 5
REQUEST SECTION:
gekkowire.com. IN ANY
ANSWER SECTION:
gekkowire.com. 14400 IN NS ns2.dreamhost.com.
gekkowire.com. 14400 IN NS ns1.dreamhost.com.
gekkowire.com. 14400 IN A 69.163.150.255
gekkowire.com. 14400 IN MX 0 mx1.sub3.homie.mail.dreamhost.com.
gekkowire.com. 14400 IN MX 0 mx2.sub3.homie.mail.dreamhost.com.
gekkowire.com. 14400 IN SOA ns1.dreamhost.com. hostmaster.dreamhost.com. 2011020902 16881 1800 1814400 14400
gekkowire.com. 14400 IN NS ns3.dreamhost.com.
SECTION NOTES:
ns1.dreamhost.com. 14400 IN A 66.33.206.206
mx2.sub3.homie.mail.dreamhost.com. 14400 IN A 208.97.132.222
mx1.sub3.homie.mail.dreamhost.com. 14400 IN A 208.97.132.221
ns3.dreamhost.com. 14400 IN A 66.33.216.216
ns2.dreamhost.com. 14400 IN A 208.96.10.221
Received 294 bytes from address 208.96.10.221#53 in 83 ms
Subdomains (the first 50)
Typos (misspells)
fekkowire.com vekkowire.com bekkowire.com hekkowire.com yekkowire.com tekkowire.com gwkkowire.com gskkowire.com gdkkowire.com grkkowire.com g4kkowire.com g3kkowire.com gejkowire.com gemkowire.com gelkowire.com geokowire.com geikowire.com gekjowire.com gekmowire.com geklowire.com gekoowire.com gekiowire.com gekkiwire.com gekkkwire.com gekklwire.com gekkpwire.com | gekk0wire.com gekk9wire.com gekkoqire.com gekkoaire.com gekkosire.com gekkoeire.com gekko3ire.com gekko2ire.com gekkowure.com gekkowjre.com gekkowkre.com gekkowore.com gekkow9re.com gekkow8re.com gekkowiee.com gekkowide.com gekkowife.com gekkowite.com gekkowi5e.com gekkowi4e.com gekkowirw.com gekkowirs.com gekkowird.com gekkowirr.com gekkowir4.com gekkowir3.com | ekkowire.com gkkowire.com gekowire.com gekowire.com gekkwire.com gekkoire.com gekkowre.com gekkowie.com gekkowir.com egkkowire.com gkekowire.com gekkowire.com gekokwire.com gekkwoire.com gekkoiwre.com gekkowrie.com gekkowier.com ggekkowire.com geekkowire.com gekkkowire.com gekkkowire.com gekkoowire.com gekkowwire.com gekkowiire.com gekkowirre.com gekkowiree.com |
Location
IP: 69.163.150.255
continent: NA, country: United States (USA), city: Brea
Website value
rank in the traffic statistics: 1 620 257
There is not enough data to estimate website value.
Basic information
website build using CSS
code weight: 83.28 KB
text per all code ratio: 17 %
title: GekkoWire
description:
keywords: fda calendar, pharmaceutical, pharmaceuticals, biotech investing, clinical trial data, clinical trials, small pharma blog, biotech calendar, biotechnology calendar, fda approval dates, fda approval, phase III, phase 3, phase II, phase 2, gekko, gekkowrie, gekkowire, gekkowrie, geckowire, geccowire, food and drug, fda, adam feuerstein, adam feurstein, adamf, genta, genasense, ampligen, nimotuzumab, nimo, YM biosciences, HemispherX, Biomoda, Cypath, cell therapeutics, opaxio, pixantrone, PGT307, AGENDA trial, CLL, EXTEND trial, Avanir, Zenvia, MS, ALS, Generex, Oral-Lyn, CombinatoRX, Exalgo, pain medication, opioid, EMBEDA, back pain, EMBBEDDA, Myriad
encoding: UTF-8
language: en-US
Website code analysis
one word phrases repeated minimum three times
two word phrases repeated minimum three times
three word phrases repeated minimum three times
B tags
U tags
I tags
images
file name | alternative text |
---|---|
poweredby_FFFFFF.gif | |
loading.gif | Loading ... |
displays.htm?id=jIyszEwsbIwsTA== | |
ec_load.gif | spinner |
publish.gif | iCalendar |
rightlg.gif | Cordobo Green Park 2 logo |
close.png | |
followme_grab.gif | |
logo-cgp2.png |
headers
H1
GekkoWire
Depomed (DEPO): Serada Breeze 3 Results Miss Endpoints
Daily Pharma Watch
Gentium (GENT) After Pulling Their NDA
Transcept (TSPT): Intermezzo Gets Win With Class 1 Filing, Analysis (Trading tips included)
Neoprobe (NEOP): My Opinion on the Matter of an RTF
Catalyst Corner
BioDelivery Sciences (BDSI): Misses Primary Endpoint In Pain Study
Biodel (BIOD): Discontinues Phase 1 Drugs BIOD 105 and BIOD 107, Path Forward (Risk Analysis)
Mela Sciences (MELA) Receives FDA Approvable Letter
H2
H3
H4
H5
H6
internal links
address | anchor text |
---|---|
http://www.gekkowire.com/ | Home |
#content | Content |
http://www.gekkowire.com/?feed=rss2 | RSS |
http://www.gekkowire.com/wp-login.php | Log in |
http://www.gekkowire.com/ | GekkoWire |
http://www.gekkowire.com/ | Home |
http://www.gekkowire.com/?page_id=2 | About |
http://www.gekkowire.com/?page_id=2870 | Contact/Email/Request |
http://www.gekkowire.com/?page_id=366 | My Drug Analysis Articles |
http://www.gekkowire.com/?page_id=4162 | Store |
http://www.gekkowire.com/?page_id=4788 | Today’s Pharma PR |
http://www.gekkowire.com/?p=8525 | Depomed (DEPO): Serada Breeze 3 Results Miss Endpoints |
http://www.gekkowire.com/?p=8525#more-8525 | |
http://www.gekkowire.com/?p=8525#comments | No comments |
http://www.gekkowire.com/?cat=1 | Uncategorized |
http://www.gekkowire.com/?tag=depo | DEPO |
http://www.gekkowire.com/?p=8521 | Daily Pharma Watch |
http://www.gekkowire.com/?p=8521#more-8521 | |
http://www.gekkowire.com/?p=8521#comments | No comments |
http://www.gekkowire.com/?cat=1 | Uncategorized |
http://www.gekkowire.com/?tag=ands | ANDS |
http://www.gekkowire.com/?tag=cycc | cycc |
http://www.gekkowire.com/?tag=ista | ISTA |
http://www.gekkowire.com/?tag=kv-a | KV.A |
http://www.gekkowire.com/?tag=miti | MITI |
http://www.gekkowire.com/?tag=pip | PIP |
http://www.gekkowire.com/?tag=pozn | POZN |
http://www.gekkowire.com/?tag=telk | TELK |
http://www.gekkowire.com/?p=8518 | Gentium (GENT) After Pulling Their NDA |
http://www.gekkowire.com/?p=8518#more-8518 | |
http://www.gekkowire.com/?p=8518#comments | 1 comment |
http://www.gekkowire.com/?cat=1 | Uncategorized |
http://www.gekkowire.com/?p=8516 | Daily Pharma Watch |
http://www.gekkowire.com/?p=8516#more-8516 | |
http://www.gekkowire.com/?p=8516#comments | No comments |
http://www.gekkowire.com/?cat=1 | Uncategorized |
http://www.gekkowire.com/?tag=alth | ALTH |
http://www.gekkowire.com/?tag=amag | AMAG |
http://www.gekkowire.com/?tag=onxx | ONXX |
http://www.gekkowire.com/?tag=rnn | RNN |
http://www.gekkowire.com/?p=8511 | Daily Pharma Watch |
http://www.gekkowire.com/?p=8511#more-8511 | |
http://www.gekkowire.com/?p=8511#comments | 2 comments |
http://www.gekkowire.com/?cat=1 | Uncategorized |
http://www.gekkowire.com/?tag=bpax | BPAX |
http://www.gekkowire.com/?tag=depo | DEPO |
http://www.gekkowire.com/?tag=dvax | dvax |
http://www.gekkowire.com/?tag=immu | IMMU |
http://www.gekkowire.com/?tag=insm | INSM |
http://www.gekkowire.com/?tag=isis | ISIS |
http://www.gekkowire.com/?tag=kerx | Kerx |
http://www.gekkowire.com/?tag=trgt | TRGT |
http://www.gekkowire.com/?p=8503 | Transcept (TSPT): Intermezzo Gets Win With Class 1 Filing, Analysis (Trading tips included) |
http://www.gekkowire.com/?p=8503#more-8503 | |
http://www.gekkowire.com/?p=8503#comments | 6 comments |
http://www.gekkowire.com/?cat=1 | Uncategorized |
http://www.gekkowire.com/?tag=tspt | TSPT |
http://www.gekkowire.com/?p=8501 | Daily Pharma Watch |
http://www.gekkowire.com/?p=8501#more-8501 | |
http://www.gekkowire.com/?p=8501#comments | 3 comments |
http://www.gekkowire.com/?cat=1 | Uncategorized |
http://www.gekkowire.com/?tag=ais | AIS |
http://www.gekkowire.com/?tag=cvm | cvm |
http://www.gekkowire.com/?tag=pozn | POZN |
http://www.gekkowire.com/?tag=scln | SCLN |
http://www.gekkowire.com/?tag=tspt | TSPT |
http://www.gekkowire.com/?p=8492 | Neoprobe (NEOP): My Opinion on the Matter of an RTF |
http://www.gekkowire.com/?p=8492#more-8492 | |
http://www.gekkowire.com/?p=8492#comments | 32 comments |
http://www.gekkowire.com/?cat=1 | Uncategorized |
http://www.gekkowire.com/?tag=neop | NEOP |
http://www.gekkowire.com/?p=8491 | Daily Pharma Watch |
http://www.gekkowire.com/?p=8491#more-8491 | |
http://www.gekkowire.com/?p=8491#comments | No comments |
http://www.gekkowire.com/?cat=1 | Uncategorized |
http://www.gekkowire.com/?tag=anx | anx |
http://www.gekkowire.com/?tag=nvax | NVAX |
http://www.gekkowire.com/?tag=smo | SMO |
http://www.gekkowire.com/?tag=xoma | XOMA |
http://www.gekkowire.com/?p=8487 | Catalyst Corner |
http://www.gekkowire.com/?p=8487#more-8487 | |
http://www.gekkowire.com/?p=8487#comments | 8 comments |
http://www.gekkowire.com/?cat=1 | Uncategorized |
http://www.gekkowire.com/?tag=alim | ALIM |
http://www.gekkowire.com/?tag=alxa | ALXA |
http://www.gekkowire.com/?tag=ands | ANDS |
http://www.gekkowire.com/?tag=anx | anx |
http://www.gekkowire.com/?tag=arql | ARQL |
http://www.gekkowire.com/?tag=biod | BIOD |
http://www.gekkowire.com/?tag=chtp | CHTP |
http://www.gekkowire.com/?tag=dsco | DSCO |
http://www.gekkowire.com/?tag=hznp | HZNP |
http://www.gekkowire.com/?tag=kerx | Kerx |
http://www.gekkowire.com/?tag=mdvn | MDVN |
http://www.gekkowire.com/?tag=neop | NEOP |
http://www.gekkowire.com/?tag=npsp | NPSP |
http://www.gekkowire.com/?tag=onxx | ONXX |
http://www.gekkowire.com/?tag=path | PATH |
http://www.gekkowire.com/?tag=pcrx | PCRX |
http://www.gekkowire.com/?tag=pcyc | PCYC |
http://www.gekkowire.com/?tag=psdv | PSDV |
http://www.gekkowire.com/?tag=ptie | PTIE |
http://www.gekkowire.com/?tag=rnn | RNN |
http://www.gekkowire.com/?tag=tlon | TLON |
http://www.gekkowire.com/?tag=tspt | TSPT |
http://www.gekkowire.com/?tag=ymi | YMI |
http://www.gekkowire.com/?p=8485 | Daily Pharma Watch |
http://www.gekkowire.com/?p=8485#comments | No comments |
http://www.gekkowire.com/?cat=1 | Uncategorized |
http://www.gekkowire.com/?tag=tsrx | TSRX |
http://www.gekkowire.com/?p=8483 | BioDelivery Sciences (BDSI): Misses Primary Endpoint In Pain Study |
http://www.gekkowire.com/?p=8483#more-8483 | |
http://www.gekkowire.com/?p=8483#comments | 1 comment |
http://www.gekkowire.com/?cat=1 | Uncategorized |
http://www.gekkowire.com/?tag=bdsi | BDSI |
http://www.gekkowire.com/?p=8481 | Daily Pharma Watch |
http://www.gekkowire.com/?p=8481#more-8481 | |
http://www.gekkowire.com/?p=8481#comments | No comments |
http://www.gekkowire.com/?cat=1 | Uncategorized |
http://www.gekkowire.com/?tag=actc | ACTC |
http://www.gekkowire.com/?tag=aegr | AEGR |
http://www.gekkowire.com/?tag=chtp | CHTP |
http://www.gekkowire.com/?tag=hznp | HZNP |
http://www.gekkowire.com/?tag=onxx | ONXX |
http://www.gekkowire.com/?tag=rnn | RNN |
http://www.gekkowire.com/?tag=tspt | TSPT |
http://www.gekkowire.com/?tag=ymi | YMI |
http://www.gekkowire.com/?p=8476 | Biodel (BIOD): Discontinues Phase 1 Drugs BIOD 105 and BIOD 107, Path Forward (Risk Analysis) |
http://www.gekkowire.com/?p=8476#more-8476 | |
http://www.gekkowire.com/?p=8476#comments | 10 comments |
http://www.gekkowire.com/?cat=1 | Uncategorized |
http://www.gekkowire.com/?tag=biod | BIOD |
http://www.gekkowire.com/?p=8472 | Mela Sciences (MELA) Receives FDA Approvable Letter |
http://www.gekkowire.com/?p=8472#more-8472 | |
http://www.gekkowire.com/?p=8472#comments | 4 comments |
http://www.gekkowire.com/?cat=1 | Uncategorized |
http://www.gekkowire.com/?tag=mela | MELA |
http://www.gekkowire.com/?paged=2 | |
#ViewPollResults | View Results |
http://www.gekkowire.com/?p=5206 | Avanir Pharmaceuticals (AVNR): Bulls And Bears |
http://www.gekkowire.com/?p=4815 | Arena Pharmaceuticals (ARNA) Briefing Document Prep: Bulls and Bears |
http://www.gekkowire.com/?p=4843 | Arena Lorcaserin Briefing Document Approval Analysis (Update Complete) |
http://www.gekkowire.com/?p=5306 | Avanir Pharmaceuticals (AVNR) Approval Estimate |
http://www.gekkowire.com/?p=6306 | Mannkind (MNKD) Bulls and Bears |
http://www.gekkowire.com/?p=3659 | Delcath Systems (DCTH) Share Price Target |
http://www.gekkowire.com/?p=6351 | Mannkind (MNKD): Approval Odds (My Opinion) |
http://www.gekkowire.com/?p=6287 | Mannkind (MNKD): Data Review, Including 014 Data and the Works! |
http://www.gekkowire.com/?m=201109&cat=1 | |
http://www.gekkowire.com/?m=201201&cat=1 | Jan |
http://www.gekkowire.com/?m=201110&cat=1 | October 2011 |
http://www.gekkowire.com/?m=20111028&cat=1 | 28 |
http://www.gekkowire.com/?m=201111&cat=1 | November 2011 |
http://www.gekkowire.com/?m=20111112&cat=1 | 12 |
http://www.gekkowire.com/?m=20111114&cat=1 | 14 |
http://www.gekkowire.com/?m=201112&cat=1 | December 2011 |
http://www.gekkowire.com/?m=20111208&cat=1 | 8 |
http://www.gekkowire.com/?page_id=2 | About |
http://www.gekkowire.com/?page_id=2870 | Contact/Email/Request |
http://www.gekkowire.com/?page_id=366 | My Drug Analysis Articles |
http://www.gekkowire.com/?page_id=4162 | Store |
http://www.gekkowire.com/?page_id=4788 | Today’s Pharma PR |
http://www.gekkowire.com/?m=201110 | October 2011 |
http://www.gekkowire.com/?m=201109 | September 2011 |
http://www.gekkowire.com/?m=201108 | August 2011 |
http://www.gekkowire.com/?m=201107 | July 2011 |
http://www.gekkowire.com/?m=201106 | June 2011 |
http://www.gekkowire.com/?m=201105 | May 2011 |
http://www.gekkowire.com/?m=201104 | April 2011 |
http://www.gekkowire.com/?m=201103 | March 2011 |
http://www.gekkowire.com/?m=201102 | February 2011 |
http://www.gekkowire.com/?m=201101 | January 2011 |
http://www.gekkowire.com/?m=201012 | December 2010 |
http://www.gekkowire.com/?m=201011 | November 2010 |
http://www.gekkowire.com/?m=201010 | October 2010 |
http://www.gekkowire.com/?m=201009 | September 2010 |
http://www.gekkowire.com/?m=201008 | August 2010 |
http://www.gekkowire.com/?m=201007 | July 2010 |
http://www.gekkowire.com/?m=201006 | June 2010 |
http://www.gekkowire.com/?m=201005 | May 2010 |
http://www.gekkowire.com/?m=201004 | April 2010 |
http://www.gekkowire.com/?m=201003 | March 2010 |
http://www.gekkowire.com/?m=201002 | February 2010 |
http://www.gekkowire.com/?m=201001 | January 2010 |
http://www.gekkowire.com/?m=200912 | December 2009 |
http://www.gekkowire.com/?m=200911 | November 2009 |
http://www.gekkowire.com/?m=200910 | October 2009 |
http://www.gekkowire.com/?m=200909 | September 2009 |
http://www.gekkowire.com/?m=200908 | August 2009 |
http://www.gekkowire.com/?cat=104 | Achillion |
http://www.gekkowire.com/?cat=105 | ACH-1625 |
http://www.gekkowire.com/?cat=209 | Acra |
http://www.gekkowire.com/?cat=186 | Acura |
http://www.gekkowire.com/?cat=112 | Advaxis |
http://www.gekkowire.com/?cat=93 | AEterna Zentaris |
http://www.gekkowire.com/?cat=29 | Antigenics |
http://www.gekkowire.com/?cat=120 | Arena |
http://www.gekkowire.com/?cat=160 | Ariad |
http://www.gekkowire.com/?cat=243 | ArQule Inc |
http://www.gekkowire.com/?cat=15 | Avanir |
http://www.gekkowire.com/?cat=16 | Zenvia |
http://www.gekkowire.com/?cat=19 | Biomoda |
http://www.gekkowire.com/?cat=3 | Cell Therapeutics |
http://www.gekkowire.com/?cat=9 | Opaxio |
http://www.gekkowire.com/?cat=4 | Pixantrone |
http://www.gekkowire.com/?cat=220 | Celldex |
http://www.gekkowire.com/?cat=26 | CombinatoRX |
http://www.gekkowire.com/?cat=61 | Exalgo |
http://www.gekkowire.com/?cat=87 | cyclacel |
http://www.gekkowire.com/?cat=235 | Delcath |
http://www.gekkowire.com/?cat=76 | Dendreon |
http://www.gekkowire.com/?cat=13 | Dr. Pazdur |
http://www.gekkowire.com/?cat=12 | FDA/Events |
http://www.gekkowire.com/?cat=6 | Genasense |
http://www.gekkowire.com/?cat=56 | Generex |
http://www.gekkowire.com/?cat=150 | AE37 |
http://www.gekkowire.com/?cat=57 | Oral-Lyn |
http://www.gekkowire.com/?cat=5 | Genta |
http://www.gekkowire.com/?cat=10 | 8.26.09 Conference Call Transcript |
http://www.gekkowire.com/?cat=99 | GenVec |
http://www.gekkowire.com/?cat=175 | Geron |
http://www.gekkowire.com/?cat=231 | Hana Biosciences |
http://www.gekkowire.com/?cat=7 | HemispherX |
http://www.gekkowire.com/?cat=8 | Ampligen |
http://www.gekkowire.com/?cat=189 | Human Genome Sciences |
http://www.gekkowire.com/?cat=233 | Immunocellular Therapeutics |
http://www.gekkowire.com/?cat=135 | intermune |
http://www.gekkowire.com/?cat=17 | Keryx |
http://www.gekkowire.com/?cat=18 | Perifosine |
http://www.gekkowire.com/?cat=181 | Labopharm |
http://www.gekkowire.com/?cat=170 | Lifeline Biotech |
http://www.gekkowire.com/?cat=60 | mannkind |
http://www.gekkowire.com/?cat=238 | Nektar |
http://www.gekkowire.com/?cat=178 | Novelos |
http://www.gekkowire.com/?cat=163 | Power 3 |
http://www.gekkowire.com/?cat=197 | Pozen |
http://www.gekkowire.com/?cat=192 | Rexahn |
http://www.gekkowire.com/?cat=68 | Sunesis |
http://www.gekkowire.com/?cat=69 | Voreloxin |
http://www.gekkowire.com/?cat=1 | Uncategorized |
http://www.gekkowire.com/?cat=113 | Vivus |
http://www.gekkowire.com/?cat=131 | Qnexa |
http://www.gekkowire.com/?cat=14 | YM Biosciences |
http://www.gekkowire.com/?cat=245 | ZIOPHARM Oncology |
# | img |
# | img |
# | img |
#home | Back to Top |
external links
address | anchor text |
---|---|
http://www.aweber.com/permission.htm | We respect your email privacy |
http://blog.firetree.net/?ec3_version=3.1.4 | EC |
http://blog.firetree.net/?ec3_version=3.1.4 | EC |
http://www.biorunup.com | BioRunUp |
http://www.biotechduediligence.com/ | Biotechduediligence |
http://www.chasingthealpha.com/ | Chasingthealpha |
http://www.greenstocks101.com | Green Stocks |
http://www.trokalayjian.com/ | Tro Kalayjian |
http://twitter.com/Gekkowire | |
http://wpease.com/find-me-else-where | Get this plugin for my blog |
http://www.ignitesocialmedia.com/tools/follow-me/ | grab this |
http://www.ignitesocialmedia.com/tools/follow-me/ | grab this |
http://www.ignitesocialmedia.com/tools/follow-me/ | img |
http://www.ignitesocialmedia.com/tools/follow-me/ | grab this |
http://wordpress.org/ | WordPress |
http://cordobo.com/green-park-2/ | Green Park 2 |
http://cordobo.com/ | Cordobo |